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The  evidence on impact of intradialytic exercise on the removal of urea, is conflictive. Impact of 
exercise on kinetics of serum levels of protein-bound uraemic toxins, known to exert toxicity and to 
have kinetics dissimilar of those of urea, has so far not been explored. Furthermore, if any effect, 
the most optimal intensity, time point and/or required duration of intradialytic exercise to maximise 
removal remain obscure. We therefore studied the impact of different intradialytic cycling 
schedules on the removal of protein-bound uraemic toxins during haemodialysis (HD). 
This randomised cross-over study included 7 stable patients who were dialysed with an FX800 
dialyser during three consecutive midweek HD sessions of 240min: A) without cycling; B) cycling for 
60 minutes between 60th-120thmin of dialysis; and C) cycling for 60 minutes between 150th-
210thmin, with the same cycling load as in session B. Blood and dialysate flows were respectively 
300 and 500mL/min. Blood was sampled from the blood inlet at different time points, and dialysate 
was partially collected (300mL/h). Small water soluble solutes and protein-bound toxins were 
quantified and intradialytic reduction ratios (RR) and overall removal were calculated per solute. 
Total solute removal and reduction ratios were not different between the 3 test sessions, except for 
the reduction ratios RR60-120 and RR150-210 for potassium.  
In conclusion, we add evidence to the existing literature that, regardless of the timing within the 
dialysis session, intradialytic exercise has no impact on small solute clearance, and demonstrated 







During the past decennia it became more obvious that, apart from successive improvements in 
commercially available haemodialysers, one should focus more on the patient to increase dialysis 
adequacy 1, 2. Dialysis strategies such as more frequent and more prolonged dialysis have proven 
benefit for the removal of numerous uraemic toxins 3, 4. While different changes in dialysis strategy 
might have some beneficial effects on removal of small water soluble solutes and middle molecules 
3, 5-7, only processing larger volumes of blood on a weekly basis seems to have a beneficial impact 
on the removal of protein-bound toxins 8. Since this can only be obtained by substantially increasing 
dialysis time per week, this option is less or even not suitable for regular in-centre haemodialysis. 
As not all patients are candidates for nocturnal or home dialysis, other alternative tracks to enhance 
protein-bound toxins are being investigated 9, 10. 
Already in the late 90’s, intradialytic exercise has been promoted to increase small solute based 
dialysis adequacy 11. While different studies showed improved reduction ratios and/or solute 
removal for urea 12-17, several more recently performed studies could however not confirm these 
findings 18-20. A systematic review of the current literature thus described a lack of efficacy for 
intradialytic exercise to enhance urea clearance 21. However, urea is not representative for the 
kinetics of other small and water soluble toxins, such as phosphate 22-24. For this molecule, 
intradialytic exercise appeared to be efficacious at improving its removal 12, 19, 20, 25. Especially for 
protein-bound uraemic toxins, kinetics are substantially dissimilar from those of urea 8, 26. The 
improved muscle perfusion during cycling might increase the release of free fraction of protein-
bound uraemic toxins from the deeper compartments in the body, changing the equilibrium 
between bound and free fractions, with eventually more removal of the free fraction. Furthermore, 
physical exercise may also augment intestinal microbial diversity through several mechanisms 
including the promotion of an anti-inflammatory state 27, lowering protein-bound toxin 
concentrations, and hence impacting removal. However, up to date, there are no data on the effect 
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of intradialytic exercise on the removal of these hard to remove toxins. There is also no consensus 
about the best time point, duration and intensity of cycling 21. 
As a result, and despite the promising findings for phosphate, which could alleviate the pill burden, 
cycling during dialysis is not applied on a systematic basis in most dialysis centres, even not in those 
where bikes are available. A positive impact of intradialytic cycling on removal of protein-bound 
toxins, known to exert toxicity and to be related to outcome, could be a convincing argument to 
promote cycling during dialysis 28. 
Therefore, the aim of the present study was to investigate 1) the impact of intradialytic cycling on 
the removal of protein-bound uraemic toxins as compared to small water soluble solutes, 2) how 
cycling influences the internal kinetics of uraemic toxins, and 3) whether timing of cycling within the 











This is a prospective randomised cross-over study, designed according the Declaration of Helsinki, 
approved by the local Ethics Committee. Written informed consent was obtained from all 
participants (EC2014/0106 - B670201419836). Exclusion criteria were age below 18, a poor 
functioning vascular access, active infection, unstable cardiac condition, and not being able to bike 
for 60min. Fourteen patients were considered eligible for inclusion, and eight of these patients 
finally were enrolled in the study (figure 1). One of them could for medical reasons not attend one 
of the test sessions and was further excluded from all analyses. The remaining seven stable chronic 
haemodialysis patients (4 male, 1 with diabetes mellitus) were 68[45;75] years, spent 50±32 months 
on dialysis, had a body weight of 74±22 kg and a residual kidney function of 1.2[0.0;6.1] mL/min at 
the time of inclusion (table 1). Five patients had a well-functioning arteriovenous fistula as vascular 
access, i.e. fistula flow was higher than 600mL/min as measured with Blood Temperature 
Monitoring (BTM) during monthly follow-up, and two patients a Palindrome 14.5F central venous 
catheter (Covidien, USA).  
Study design 
During three consecutive weeks, the midweek session was studied. Haemodialysis was performed 
for at least 4 hours with an FX800 haemodialyser on a Fresenius 5008 dialysis machine (both 
Fresenius Medical Care, Bad Homburg, Germany). Blood and dialysate flows were set at 300 and 
500mL/min, respectively, while ultrafiltration was set manually according to the patient’s need. 
Ultrafiltration was kept constant during each test session, but could be different among the three 
sessions. Dialysate temperature was maintained at 36°C during the three midweek test sessions (A, 
B, and C). Session A was a dialysis session without any cycling (control), while during session B and 
C, the patient was asked to cycle for 60 minutes, but at different time points within the dialysis 
session: either from minute 60 to 120 or from minute 150 to 210 after dialysis start (figure 2), 
without a warm-up period. Biking was performed on a Motomed Letto 2 bike (Reck, Betzenweiler, 
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Germany), operated and installed by skilled dialysis staff. Patients were neither tested nor asked for 
their physical capacities and could choose for themselves the resistance and number of rotations 
but had to keep these fixed during both cycling intervals in sessions B and C. 
Sampling and analysis 
During the three midweek test sessions, blood was sampled from the vascular access predialysis, 
and from the blood inlet line at 15, 30, 60, 90, 120, 150, 180, 210, and 240min after the start of the 
session (figure 2). Blood samples were centrifuged (10min at 1250g, 4°C) after 20-30min at room 
temperature to allow clotting, after which the serum was aliquoted and stored at -80°C until batch 
analysis. Spent dialysate was partially collected during the entire session (300mL/h) using a 
calibrated sampling system (including an infuse pump type Alaris® GP plus; Cardinal Health, 
Switzerland).  
Urea, creatinine (Crea), potassium (K), and phosphate (P) were measured by standard laboratory 
methods. Other solutes were determined by reversed-phase high performance liquid 
chromatography (RP-HPLC), as described earlier 29. These included uric acid (UA, 168Da), and the 
protein-bound solutes p-cresyl glucuronide (PCG), hippuric acid (HA), indole acetic acid (IAA), 
indoxyl sulfate (IxS), and p-cresyl sulfate (PCS). To determine the total concentration, serum samples 
were first deproteinised by heat denaturation prior to HPLC analysis 29. HA was analysed by UV 
detection at 254nm, and UA at 300nm, whereas pCG and pCS (λexc = 265nm, λem = 290nm) and 
IAA and IxS (λexc = 280nm, λem = 340nm) were determined by fluorescence detection 7, 30.  
Measurements and calculations 
During the three test sessions, accurate monitoring of pulse, blood pressure, blood volume (BVM: 
blood volume monitoring) and temperature (BTM: blood temperature monitoring) was performed 
using features on the dialysis machine, at the time points of blood sampling as well as every 15 
minutes during cycling.  
Percentage protein binding was calculated from the total CT and free concentration CF of the 
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The bound concentrations of protein-bound toxins at time point t after dialysis start t0 were 
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Total Solute Removal (TSR) was calculated from the processed dialysate volume (VD) and the toxin 
concentration in the collected spent dialysate (CD): 
DD VC TSR             (4) 
Statistical analysis 
All statistical analyses were performed using SPSS Statistics 25 (SPSS Inc, Chicago, IL). Data are 
expressed as mean ± standard deviation or median[25th;75th percentile]. Statistical analyses were 




For the seven patients completing the test protocol as foreseen, all data of the three randomised 
mid-week dialysis sessions were used in the analysis (figure 1). Also, no side effects were revealed 
during the test sessions. For the only patient dialysing longer than 240min (i.e. 270min), the last test 
sample and data were collected at 240min. Ultrafiltration volumes were not different among the 
three different test sessions, respectively 1.36±0.94L, 1.43±1.09L, and 1.14±1.11L. Patient’s 
medication and bicarbonate dialysate concentrate were not changed during the three test weeks 
(table 1).  
Table 2 shows the cycling characteristics of the seven patients which were similar for dialysis 
sessions B (cycling from 60-120min) and session C (cycling from 150-210min). All patients performed 
the cycling according to their physical possibilities, explaining the wide variety for the achieved 
resistance as well as the frequency of rotations (i.e. suppleness). 
The mean serum concentrations during the three dialysis sessions are presented in figure 3 for the 
protein-bound solutes and in figure 4 for the small water soluble solutes, with the data for sessions 
A, B, and C in the respective panels. While most toxins show an exponential-like concentration 
decrease during the course of dialysis, potassium and phosphate concentrations tended to increase 
during cycling in session B (potassium only) and C (figure 4). 
Table 3 shows the reduction ratios for the three test sessions, as calculated over the total 4h dialysis 
session (RR0-240), and over both 60min cycling intervals (i.e. RR60-120 and RR150-210). Cycling did neither 
affect the reduction ratios of the protein-bound toxins nor of the small water soluble solutes, apart 
from potassium. For the latter, RR60-120 (ANOVA P=0.025) was significantly lower and even became 
negative during the cycling interval (session B) as compared to sessions A (P=0.012) and C (P=0.043). 
Also RR150-210 for potassium (ANOVA P=0.005) was lower and even negative during the cycling 




For none of the studied solutes, differences in Total Solute Removal (TSR) could be measured (figure 
5). 
Although several individual fluctuations could be observed in the relative blood volume (BVM) 
during the dialysis course, blood volume variation from start to end of dialysis was not different 
among the three dialysis sessions. 
Several registered parameters, i.e. pulse, blood pressure, and temperature, illustrated that the 
intensity of cycling in sessions B and C were comparable, and that baseline parameters were similar 
for all sessions.  
At rest, pulse was not different between the different sessions: i.e. 67±3bpm (session A) versus 
67±4bpm (B) and 66±2bpm (C). Pulse increased significantly during cycling in session B (median 
pulse 82±10bpm and top 102±26bpm) and session C (median 84±7bpm and top 94±16bpm), but no 
differences were found for the median and top pulses between session B and C.  
In a similar way, systolic blood pressure at rest was not different between the three sessions (i.e. 
134[85;141]mmHg in session A, 124[88;138]mmHg in session B, and 120[94;150]mmHg in session 
C), and no differences were observed for the mean and top systolic blood pressure during cycling 
between session B and C (i.e. mean 128[93;150] and top 135[109;156]mmHg in session B, and mean 
143[93;155] and top 164[102;173]mmHg in session C). 
Blood temperature, as registered by BTM, increased during the cycling interval by 0.5±0.2°C (session 
B) and 0.5±0.4°C (session C). Post dialysis, blood temperature was still 0.3±0.4°C (session B) and 
0.4±0.2°C (session C) higher than at 15min after dialysis start, and these increases were significantly 






The recently performed systematic review by Kirkman et al. was clear in its conclusion 21: while it 
remains uncertain whether intradialytic exercise can improve dialysis adequacy in terms of urea 
removal, the impact on the removal of the more toxic protein-bound toxins as well as the evidence 
of effective exercise prescription parameters, are still unexplored. The present study focused on the 
effect of cycling during dialysis on removal of protein-bound toxins, and assessed whether timing of 
cycling during the dialysis session had an impact. Our main findings are that, (1) intradialytic cycling 
did not improve the removal of protein-bound toxins, and this irrespective of timing within the 
dialysis session; (2) no improvement in the removal of urea was observed; and (3) potassium serum 
concentrations were increased during the cycling interval but this did not result in enhanced 
removal. 
The underlying hypothesis of intradialytic exercise increasing dialysis adequacy, includes increased 
blood perfusion between the working muscle and the bloodstream, thereby increasing the transport 
of toxins to the plasma and thus enabling more toxin removal during dialysis. In case this enhanced 
intercompartmental transport is higher than dialyser removal, plasma concentrations might even 
increase during cycling. From this respect, the reduction ratio, as calculated from pre and post 
dialysis plasma concentrations, is no overall suitable marker to quantify the impact of cycling. On 
the contrary, total solute removal, as calculated from spent dialysate volume and concentrations, 
provides a more objective way to quantify the impact of cycling. The present finding that protein-
bound uraemic toxins do not take advantage of this enhanced transport inside the patient, teaches 
us that either the release of these toxins into the plasma is very limited or that the (immediate) 
protein binding of the solute released into the plasma prevents its removal. Also, the variation of 
gut microbiota, influencing PBUT concentrations and removal, might only become important on the 
long run when exercise is performed on a regular basis. 
Many contradictory results on the impact of intradialytic cycling on urea removal have been 
published over the last two decades 11-18, 20, 25, 31. In our study, no impact of cycling was found. Most 
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studies showing an increased Kt/Vurea were RCTs running over several weeks (8-20 weeks) 14-17. This 
suggests that the improvement of Kt/Vurea with cycling might be more the result of a long term 
effect, such as improved body composition by reduction of extracellular water or improved 
nutritional status32. Unfortunately, many of the cross-over studies finding a positive impact are 
rather old and lack sufficient details to develop or unravel potential mechanistic hypotheses 11-13. 
And this is also the case for the more recently performed studies which share the same conclusions 
as the present study 18, 20. 
In the present study, we observed only for potassium an impact of intradialytic exercise on solute 
kinetics. The negative reduction ratios during both cycling intervals can be explained by the release 
of potassium ions from the skeletal muscles leading to increased plasma concentrations 33. These 
higher concentrations should theoretically result in higher potassium removal via the dialyser. 
However, according to our results, this did not happen. It can be that the vigorous exercise induced 
neuro-hormonal activation, resulting in a rapid shift of potassium to intracellular once exercise is 
stopped, and thus a lower removal in the post-exercise period which would compensate the higher 
removal during exercise 34. This could be the case during the performance of session B, where 
patients have a substantial period of dialysis after the exercise, but of course far less during session 
C, where this period is shorter 34. Although the observed temporary hyperkalaemia during cycling is 
depending on the exercise load 13, 35, our findings with respect to the lack of an increased potassium 
removal are still in accordance to those described by Orcy et al. where patients had to cycle three 
times 20min even at a rather strong level up to 80% of their maximum heart rate 20.  
Rather surprisingly, also no increase in phosphate total solute removal was observed in the present 
study. From the complex kinetics of phosphate 22-24 it is clear that its removal is taking advantage of 
prolonged dialysis, as displacement from third compartments to the circulation is the rate limiting 
step for removal 36. From the same reasoning it could be hypothesised that the mobilisation of 
phosphate from the deeper compartments is enhanced during intradialytic exercise. This advantage 
only applies when the exercise is performed either in a moderate way every dialysis hour for at least 
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20min 12, 25 or rather intensive during the last hour of the dialysis session 19. On the contrary, exercise 
as scheduled during the first hours of dialysis seemed not to increase phosphate removal 20, 31. The 
present study adds to these findings that moderate active cycling in the interval 60-120 or 150-
210min after dialysis start did not result in enhanced phosphate removal. 
The small patient number (n=7) could be considered a limitation of the study, but this allowed us to 
have each patient as his/her own control over the 3 experimental regimens. While several other 
studies are defining the exercise intensity as a percentage of maximum heart rate or anaerobe 
threshold, we allowed the patients to choose their own exercise load to make the results more 
relevant for daily clinical practice. Also, although the physical exercise of some patients could be 
defined as rather limited, a sub-analysis including the four patients using a cycling resistance above 
5 (table 2) did not change the results. However, in order to prescribe individualised physical activity 
with a formal treatment plan, it is not sufficient to follow the patient’s choice. Instead, exercise 
professionals should assess the patient’s capabilities beforehand and should document their 
progress  37, 38. 
But our study has also several strengths. We are the first to check the kinetics of protein-bound 
uraemic toxins during intradialytic exercise, and this with a rather long exercise interval (60min) in 
the first (i.e. 60-120min) as well as in the second part of the dialysis session (i.e. 150-210min). 
Furthermore, the results of both sessions with cycling could be compared in a direct way, due to the 
prescription of an equal exercise load, as is also reflected by the outcome of other registered 
parameters during cycling like pulse, blood pressure and temperature. The intensive blood sampling 
during dialysis, with at least samples pre and post cycling, offered the opportunity to check 
intradialytic kinetics, i.e. RR60-120 and RR150-210. While reduction ratios do not reflect the net gain in 
toxin removal by intradialytic cycling, the measurement and calculation of total solute removal is a 
strong added value of this study. 
In conclusion, although our study was designed to learn more about the intradialytic kinetics of a 
whole range of uraemic toxins, we could not find any difference in removal between the sessions 
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with and without cycling, nor for the protein-bound uraemic toxins, neither for the small water 
soluble toxins. Hence, internal kinetics of uraemic toxins was not found influenced by intradialytic 
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Table 1: Patient and dialysis characteristics 
Included patients (n) 7 
Patient characteristics 
Gender (M/F) 4/3 
Age (years) 68 [45;75] 
Body weight (kg) 74 ± 22 
BMI (kg/m²) 26 ± 7 
RKF (mL/min) 1.2 [0.0;6.1] 
Dialysis vintage (months) 50 ± 32 
Etiology  myeloma kidney, tuberous sclerosis, membranous 
nephropathy, diabetic nephropathy in diabetes type II, 
atheroembolic renal disease, (acute) cortical necrosis, 
glomerulonephritis 
Medication calcium acetate (n=4), sevelamer (n=1), calcium kayexalate 
(n=1), sodium bicarbonate (n=1), alfacalcidol (n=2), 
cholecalciferol (n=1), pantoprazole (n=2), acetylsalicylic acid 
(n=2), simvastatin (n=1), dopidogrel (n=1), bumetanide (n=1), 
amplodipine (n=1), carvedilol (n=1), cyclofosfamide (n=1), 
fludrocortisone (n=1), finasteride (n=1), trazodan (n=1) 
Dialysis characteristics 
Anticoagulation  Heparin 4000IE + 1500IE/h (n=1), Tinzaparin 4500IE (n=3), 
Tinzaparin 3500IE (n=1), Enoxaparin 60mg (n=2) 
Bicarbonate dialysate 
concentrate 
K4 Ca1.5 (n=1), K3 Ca1.5 (n=1), K3 Ca1.25 (n=3), K2 Ca1.25 
(n=1), K2 Ca1.25 (n=1) 
Laboratory 
 Hb (g/dL) 10.7 ± 1.5 
 CRP (mg/L) 5.3 [ 3.0;27.2] 
 Na (mmol/L) 141 ± 1 
 K (mmol/L) 5.0 ± 0.6 
 Ca (mmol/L) 2.1 ± 0.2 
 P (mmol/L) 1.4 ± 0.4 
 Urea 
(mg/dL) 
84.6 ± 12.6 
 Creatinine 
(mg/dL) 
7.5 ± 1.6 
 Albumin 
(g/L) 
38.8 ± 4.6 
 Total protein 
(g/L) 
62.3 ± 4.0 
 PTH (ng/L) 231 [166;361] 











Table 3: Reduction ratios for different time intervals during dialysis for the different sessions A, B, 
and C. 
Solute RR0-240 RR60-120 RR150-210 
 A B C A B C A B C 
Protein-bound uraemic toxins 
PCG 78 ± 11 78 ± 13 72 ± 32 35 ± 8 33 ± 6 31 ± 15 25 ± 13 23 ± 15 20 ± 24 
HA 69 ± 8 70 ± 12 67 ± 19 27 ± 8 26 ± 8 27 ± 5 22 ± 8 22 ± 2 22 ± 8 
IAA 44 ± 8 43 ± 9 51 ± 10 8 ± 10 11 ± 8 14 ± 5 12 ± 7 9 ± 6 13 ± 7 
IxS 34 ± 5 32 ± 9 38 ± 8 8 ± 8 6 ± 11 8 ± 4 7 ± 6 6 ± 6 8 ± 5 
PCS 29 ± 4 28 ± 7 32 ± 8 6 ± 6 6 ± 11 7 ± 4 6 ± 5 5 ± 5 5 ± 4 
Small water soluble solutes 
Urea 78 ± 3 78 ± 4 77 ± 4 30 ± 3 27 ± 2 29 ± 3 29 ± 4 29 ± 4 27 ± 3 
Crea 70 ± 3 70 ± 5 69 ± 4 23 ± 4 21 ± 3 23 ± 2 21 ± 2 21 ± 4 18 ±3 
P 59 ± 5 61 ± 7 63 ± 6 14 ± 14 13 ± 8 22 ± 3 1 ± 14 -1 ± 11 -11 ± 9 
K 22 ± 12 20 ± 10 24 ± 14 5 ± 3 α -7 ± 6* 5 ± 6† 1 ± 3 α 2 ± 4 -9 ± 3*† 
UA 79 ± 6 79 ± 5 78 ± 4 31 ± 4 30 ± 4 31 ± 3 26 ± 5 27 ± 4 26 ± 5 
RR: reduction ratio; PCG: p-cresyl glucuronide; HA: hippuric acid; IAA: indole acetic acid; IxS: indoxyl sulfate; PCS: p-
cresyl sulfate; P: phosphate; K: potassium; UA: uric acid. 
α repeated measures ANOVA P<0.05 




Patient Resistance  Rotations/min 
1 0 75 
2 6 90 
3 6 80 
4 10 60 
5 4 80 
6 15 90 











Figure 2: Protocol of cycling (grey bars) and blood sampling (arrows) in the three midweek sessions 






Figure 3: Profiles of mean concentrations of protein-bound uraemic toxins along the session without 
cycling (session A - panel A), with cycling from 60-120min (session B - panel B), and with cycling from 
150-210min (session C - panel C). Cycling intervals are indicated in grey. IxS: indoxyl sulfate, PCS: p-
















Figure 4: Profiles of mean concentrations of small water soluble solutes along the session without 
cycling (session A - panel A), with cycling from 60-120min (session B - panel B), and with cycling from 
150-210min (session C - panel C). Cycling intervals are indicated in grey. Crea: creatinine, P: 











































































































































Figure 5: Total Solute Removal (TSR) of small water soluble solutes (panel A) and protein-bound 
solutes (panel B) in the three midweek sessions A, B, and C. Crea: creatinine, P: phosphate, K: 
potassium, UA: uric acid, PCG: p-cresyl glucuronide, HA: hippuric acid, IAA: indole acetic acid, IxS: 

































s s ion C
s s ion B
s s ion A
